Una píldora anticonceptiva masculina no hormonal nueva es altamente efectiva en los ratones y podrían comenzar las pruebas en humanos en el 2022, según los investigadores.
Related Posts
AHA News: New York City Attorney Was the Picture of Good Health, Until His Doctor Detected a Heart Murmur
THURSDAY, Oct. 14, 2021 (American Heart Association News) -- A lifelong athlete...
U.S. Gun Deaths Reach New Highs
THURSDAY, Oct. 6, 2022 (HealthDay News) -- Murders and suicides involving guns...
New Tick-Borne Virus Is Spreading Across U.S.
THURSDAY, March 17, 2022 (HealthDay News) -- The potentially deadly tick-borne...
‘Mix and Match’? Study Supports Following J&J Vaccine With Pfizer, Moderna
THURSDAY, Oct. 14, 2021 (HealthDay News) -- Americans who got Johnson &...